mAb,Control.1,Control.2,Nb13373.1,Nb13373.2,Control.1,Control.2,Nb13373.1,Nb13373.2
HG with a low DE (mAb JIM5),35,40,47,41,0,0,0,0
HG with a high DE (mAb JIM7),66,70,89,81,0,0,0,0
HG Partially methylesterified (mAb LM18),28,29,41,36,15,16,14,18
HG Partially methylesterified (mAb LM19),33,34,54,46,43,46,36,40
HG Partially methylesterified (mAb LM20),33,41,56,41,0,0,0,0
Backbone of rhamnogalacturonan I (mAb INRA-RU1),46,51,60,56,58,58,47,51
Backbone of rhamnogalacturonan I (mAb INRA-RU2),47,52,68,63,72,73,68,73
(1→4)-β-D-galactan (mAb LM5),68,72,50,52,89,94,61,64
(1→5)-α-L-arabinan (mAb LM6),57,58,57,57,75,76,58,62
(1→4)-β-D-(galacto)(gluco)mannan (mAb LM21),0,0,0,0,29,31,30,29
(1→3)(1→4)-β-D-glucan (mAb BS-400-3),0,0,0,0,0,0,5,10
Xyloglucan (XXXG motif) (mAb LM15),0,0,0,9,28,34,36,31
(1→4)-β-D-xylan (mAb LM10),0,0,0,0,0,31,32,17
(1→4)-β-D-xylan/arabinoxylan (mAb LM11),0,0,0,0,9,25,28,21
Extensin (mAb LM1),10,6,21,14,0,0,0,0
Extensin (mAb JIM11),8,6,21,14,6,6,10,9
Extensin (mAb JIM12),6,0,12,8,0,0,0,0
Extensin (mAb JIM20),20,14,38,28,9,8,16,12
AGP (mAb JIM8),35,33,35,30,28,24,12,12
AGP (mAb JIM13),47,49,41,37,52,51,35,35
AGP (mAb JIM16),8,9,11,9,0,0,0,0
"AGP, β-linked GlcA (mAb LM2)",17,13,15,12,6,6,6,6